News 2023-07-28
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Dear valued customers and partners,
We would like to extend our gratitude for your continuous support towards Porton Pharma Solutions Ltd. In order to further enhance the company's brand recognition, adapt to our global development strategy, improve communication efficiency, and protect each other's information security, we have decided to change our email domain name from porton.cn to portonpharma.com.
We will be discontinuing the use of the old email addresses and will automatically forward all emails sent to the old addresses to the new address in the coming weeks or so. To avoid any unnecessary delays, we strongly recommend that you start using the new email address to contact us starting from August 13, 2023.
We look forward to maintaining closer contact with you and achieving greater business success together. If you have any questions or need further assistance, please feel free to contact us at any time.
We apologize for any inconvenience caused by this change and appreciate your understanding!
Chinese website: www.porton.cn
English website: www. portonpharma.com
Others
More
News 2024-11-13
Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials.
During the Slovenian government delegation's visit to Shanghai, the Slovenian Consulate in Shanghai and the Shanghai Municipal Commission for Trade Promotion hosted the "China–Slovenia Business and Investment Forum" on November 4th, 2024.
News 2024-11-09
Porton’s New Modality Capacity Upgrade Ceremony Successfully Held
On November 7, 2024, the New Modality Capacity Upgrade Ceremony was successfully held in Fengxian, Shanghai, China. Attendees included Mr. Weng Jun，Vice General Manager，Shanghai Hangzhou Bay Economic & Technological Development Co., Ltd., Mr. Bai Yinchun, COO and Senior Vice President of Porton, Ms. Pi Wei, Vice President and Board Secretary of Porton, Ms. Meng Fan, Deputy General Manager of the Sales & Marketing Center of Porton, and Mr. Xie Lihua, Head of the Synthetic Macromolecules Service Department. Together, they witnessed this significant moment of enhancing the production capacity for new modalities at the Fengxian site.
